Veronica Dusi1, Leila Shahabi2, Rachel C Lapidus3, Julie M Sorg4, Bruce D Naliboff2, Kalyanam Shivkumar4, Sahib S Khalsa5, Olujimi A Ajijola6. 1. Department of Molecular Medicine, Section of Cardiology, University of Pavia, Pavia, Italy; UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, California. 2. Oppenheimer Center for the Neurobiology of Stress and Resilience, David Geffen School of Medicine at UCLA, Los Angeles, California. 3. Laureate Institute for Brain Research, Tulsa, Oklahoma. 4. UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, California. 5. Laureate Institute for Brain Research, Tulsa, Oklahoma; Oxley College of Health Sciences, University of Tulsa, Tulsa, Oklahoma. 6. UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: oajijola@mednet.ucla.edu.
Abstract
BACKGROUND: Bilateral cardiac sympathetic denervation (BCSD) is an effective therapy for ventricular arrhythmias (VAs) in cardiomyopathies (CMPs). After BCSD, residual autonomic nervous system (ANS) function is unknown. OBJECTIVE: The purpose of this study was to assess ANS responses in patients with CMP before and after BCSD as compared with demographically matched healthy controls. METHODS: Patients with CMP undergoing BCSD and matched healthy controls were recruited. Noninvasive measures-finger cuff beat-to-beat blood pressure (BP), electrocardiography, palmar electrodermal activity (EDA), and finger pulse volume (FPV)-were obtained at rest and during autonomic stressors-posture change, handgrip, and mental stress. Maximal as well as specific responses to stressors were compared. RESULTS: Eighteen patients with CMP (mean age 54 ± 14 years; 16 men, 89%; left ventricular ejection fraction 36% ± 14%) with refractory VAs and 8 matched healthy controls were studied; 9 patients with CMP underwent testing before and after (median 28 days) BCSD, with comparable ongoing medication. Before BCSD, patients with CMP (n = 13) had lower resting systolic BP and FPV than did healthy controls (P < .01). Maximal FPV and systolic BP reflex responses, expressed as percent change were similar, while diastolic BP, mean BP, and EDA responses were blunted. After BCSD, resting measurements were unchanged relative to presurgical baseline (n = 9). EDA responses to stressors were abolished, confirming BCSD, while maximal FPV and BP responses were preserved. Diastolic BP, mean BP, and FPV responses to orthostatic challenge pointed toward a better tolerance of active standing after BCSD as compared with before. Responses to other stressors remained unchanged. CONCLUSION: Patients with CMP and refractory VAs on optimal medical therapy have detectable but blunted adrenergic responses, which are not disrupted by BCSD.
BACKGROUND: Bilateral cardiac sympathetic denervation (BCSD) is an effective therapy for ventricular arrhythmias (VAs) in cardiomyopathies (CMPs). After BCSD, residual autonomic nervous system (ANS) function is unknown. OBJECTIVE: The purpose of this study was to assess ANS responses in patients with CMP before and after BCSD as compared with demographically matched healthy controls. METHODS:Patients with CMP undergoing BCSD and matched healthy controls were recruited. Noninvasive measures-finger cuff beat-to-beat blood pressure (BP), electrocardiography, palmar electrodermal activity (EDA), and finger pulse volume (FPV)-were obtained at rest and during autonomic stressors-posture change, handgrip, and mental stress. Maximal as well as specific responses to stressors were compared. RESULTS: Eighteen patients with CMP (mean age 54 ± 14 years; 16 men, 89%; left ventricular ejection fraction 36% ± 14%) with refractory VAs and 8 matched healthy controls were studied; 9 patients with CMP underwent testing before and after (median 28 days) BCSD, with comparable ongoing medication. Before BCSD, patients with CMP (n = 13) had lower resting systolic BP and FPV than did healthy controls (P < .01). Maximal FPV and systolic BP reflex responses, expressed as percent change were similar, while diastolic BP, mean BP, and EDA responses were blunted. After BCSD, resting measurements were unchanged relative to presurgical baseline (n = 9). EDA responses to stressors were abolished, confirming BCSD, while maximal FPV and BP responses were preserved. Diastolic BP, mean BP, and FPV responses to orthostatic challenge pointed toward a better tolerance of active standing after BCSD as compared with before. Responses to other stressors remained unchanged. CONCLUSION:Patients with CMP and refractory VAs on optimal medical therapy have detectable but blunted adrenergic responses, which are not disrupted by BCSD.
Authors: H R Middlekauff; A H Nguyen; C E Negrao; E U Nitzsche; C K Hoh; B A Natterson; M A Hamilton; G C Fonarow; A Hage; J D Moriguchi Journal: Circulation Date: 1997-09-16 Impact factor: 29.690
Authors: A Mortara; M T La Rovere; G D Pinna; A Prpa; R Maestri; O Febo; M Pozzoli; C Opasich; L Tavazzi Journal: Circulation Date: 1997-11-18 Impact factor: 29.690
Authors: Alwin Zweerink; Anne-Lotte C J van der Lingen; M Louis Handoko; Albert C van Rossum; Cornelis P Allaart Journal: Circ Heart Fail Date: 2018-08 Impact factor: 8.790
Authors: Anne-Sophie G T Bronzwaer; Lysander W J Bogert; Berend E Westerhof; Jan J Piek; Mat J A P Daemen; Johannes J van Lieshout Journal: ESC Heart Fail Date: 2017-02-26
Authors: Sahib S Khalsa; Ashley N Clausen; Leila Shahabi; Julie Sorg; Sarah E Gonzalez; Bruce Naliboff; Kalyanam Shivkumar; Olujimi A Ajijola Journal: Auton Neurosci Date: 2021-02-14 Impact factor: 3.145